TANDEM DIABETES CARE INC (TNDM)
Health Care / Health Care Equipment
S&P SmallCap 600$18.82
Below average on several measures. Research carefully.
Consider Buy
Score based on 4 of 5 models — moderate confidence
Is TANDEM DIABETES CARE INC a Good Investment in 2026?
TANDEM DIABETES CARE INC (TNDM) scores 5.3 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model is the most favorable, rating TANDEM DIABETES CARE INC as Neutral. However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 98%). TANDEM DIABETES CARE INC ranks #497 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Currently unprofitable — fair value estimate not available.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Neutral
4/9
Buffett
Caution
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Caution
Bottom half (rank 98%)
Frequently Asked Questions
Is TANDEM DIABETES CARE INC (TNDM) a good investment?
What is TANDEM DIABETES CARE INC's Piotroski F-Score?
Is TNDM overvalued or undervalued?
How does TNDM compare to other Health Care stocks?
What do investment models say about TNDM?
Similar Stocks
Compare TNDM with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer